Breaking News, Promotions & Moves

Genentech

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genentech has promoted three senior vice presidents, Ian T. Clark, commercial operations, David Ebersman, chief financial officer, and Patrick Yang, Ph.D., product operations, to executive vice president. All three will continue to serve on the company’s executive committee and will report to chairman and chief executive officer, Arthur D. Levinson, Ph.D.

Mr. Clark is responsible for leading the company’s commercial operations, including sales, marketing, managed care, and commercial development. He joined Genentech in January 2003 as senior vice president and general manager, BioOncology. Prior to joining the company, he served as president, Novartis Canada and also served as chief operating officer for Novartis UK. Prior to joining Novartis in 1999, he worked in positions of increasing strategic importance in sales, marketing and business development at Ivax Pharma and Sanofi-Synthelabo in the UK.

Mr. Ebersman is responsible for Genentech’s finance, corporate relations, investor relations and corporate information technology groups. He joined the company in 1994 and previously held several positions in business development and product development. He was named senior director of product development in 1998, vice president of product development in 1999 and senior vice president of product operations in 2001. Before joining the company, he served as a research analyst covering biotechnology investments at Oppenheimer & Company, Inc. (now CIBC World Markets).

Mr. Yang is responsible for the company’s manufacturing, engineering, process development and supply chain management organizations. He joined Genentech in December 2003 from Merck & Co., where he worked for 11 years and held several leadership roles in the manufacturing division. Most recently, he held the position of vice president, supply chain management. In this role, he led the materials management, strategic planning and manufacturing support functions for Merck’s worldwide manufacturing plants. Prior to that, he was Merck’s vice president, Asia/Pacific manufacturing operations.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters